Cargando…
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)
BACKGROUND: Clinical practice guidelines for the treatment of major depressive disorder (MDD) recommend antidepressants for patients with moderate-severe depression and active monitoring for patients with mild-moderate symptoms. The feasibility and efficiency of active monitoring has not been proven...
Autores principales: | Rubio-Valera, Maria, Beneitez, Imma, Peñarrubia-María, María Teresa, Luciano, Juan V, Mendive, Juan M, McCrone, Paul, Knapp, Martin, Sabés-Figuera, Ramon, Kocyan, Katarzyna, García-Campayo, Javier, Serrano-Blanco, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394418/ https://www.ncbi.nlm.nih.gov/pubmed/25885818 http://dx.doi.org/10.1186/s12888-015-0448-3 |
Ejemplares similares
-
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
por: Luciano, Juan V, et al.
Publicado: (2014) -
Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
por: Rubio-Valera, Maria, et al.
Publicado: (2013) -
Correction: Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
por: Rubio-Valera, Maria, et al.
Publicado: (2016) -
Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol
por: Rubio-Valera, Maria, et al.
Publicado: (2009) -
The hidden cost of chronic fatigue to patients and their families
por: Sabes-Figuera, Ramon, et al.
Publicado: (2010)